Cargando…

Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer

Immunotherapy has emerged as a promising modality for cancer treatment. Dendritic cell immunoreceptor (DCIR), a C-type lectin receptor, is expressed mainly by dendritic cells (DCs) and mediates inhibitory intracellular signaling. Inhibition of DCIR activation may enhance antitumor activity. DCIR is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Che-Yuan, Hung, Chi-Feng, Chen, Pi-Che, Hsu, Jia-Yu, Wang, Chung-Teng, Lai, Ming-Derg, Tsai, Yuh-Shyan, Shiau, Ai-Li, Shieh, Gia-Shing, Wu, Chao-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604824/ https://www.ncbi.nlm.nih.gov/pubmed/37892972 http://dx.doi.org/10.3390/biomedicines11102598

Ejemplares similares

Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity
por: Su, Bing-Hua, et al.
Publicado: (2015)

Oncolytic Adenovirus with SPAG9 shRNA Driven by DD3 Promoter Improved the Efficacy of Docetaxil for Prostate Cancer
por: Lu, Meng, et al.
Publicado: (2022)

Stable expression of shRNA for the control of recombinant adenovirus replication
por: Lana, M.V.G., et al.
Publicado: (2023)

Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy
por: Ahn, Hyo Min, et al.
Publicado: (2016)

shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy
por: Zhang, Jie, et al.
Publicado: (2016)

Downregulation of survivin by adenovirus-mediated shRNA promotes apoptosis in skin cancer cells
por: Hao, Yuqin, et al.
Publicado: (2019)

Combination of oncolytic adenovirus and luteolin exerts synergistic antitumor effects in colorectal cancer cells and a mouse model
por: Xiao, Boduan, et al.
Publicado: (2017)

Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation
por: Kim, So Young, et al.
Publicado: (2017)

Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy
por: Wang, Weiguo, et al.
Publicado: (2013)

Construction of shRNA lentiviral vector
por: Song, Hong, et al.
Publicado: (2010)

Immunoreceptors on neutrophils
por: van Rees, Dieke J., et al.
Publicado: (2016)

Optimized PCR Conditions and Increased shRNA Fold Representation Improve Reproducibility of Pooled shRNA Screens
por: Strezoska, Žaklina, et al.
Publicado: (2012)

Biologically responsive carrier-mediated anti-angiogenesis shRNA delivery for tumor treatment
por: Che, Junyi, et al.
Publicado: (2016)

Adenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cells
por: Lee, Jung-Sun, et al.
Publicado: (2015)

shRNA target prediction informed by comprehensive enquiry (SPICE): a supporting system for high-throughput screening of shRNA library
por: Kamatuka, Kenta, et al.
Publicado: (2016)

Gene Electrotransfer of Plasmid with Tissue Specific Promoter Encoding shRNA against Endoglin Exerts Antitumor Efficacy against Murine TS/A Tumors by Vascular Targeted Effects
por: Stimac, Monika, et al.
Publicado: (2015)

The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model
por: Young, Brittany A., et al.
Publicado: (2013)

Combined Treatment with an Oncolytic Adenovirus and Antitumor Activity of Vincristine against Retinoblastoma Cells
por: Song, Xin, et al.
Publicado: (2012)

Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma
por: Tripodi, Lorella, et al.
Publicado: (2023)

Adenovirus vectors lacking virus-associated RNA expression enhance shRNA activity to suppress hepatitis C virus replication
por: Pei, Zheng, et al.
Publicado: (2013)

Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35
por: Ono, Ryosuke, et al.
Publicado: (2021)

Fc Receptors as Adaptive Immunoreceptors
por: Daëron, Marc
Publicado: (2014)

In Vivo Suppression of Autophagy via Lentiviral shRNA Targeting Atg5 Improves Lupus-Like Syndrome
por: Liu, Chi-Jui, et al.
Publicado: (2020)

Oncolytic adenovirus-mediated dual knockdown of survivin and OCT4 improves therapeutic efficacy in esophageal cancer
por: Li, Chunguang, et al.
Publicado: (2023)

Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells
por: Cheng, Pei-Hsin, et al.
Publicado: (2013)

Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma
por: Yang, Chunhua, et al.
Publicado: (2016)

Strong antitumor efficacy of a pancreatic tumor‐targeting oncolytic adenovirus for neuroendocrine tumors
por: Yamamoto, Yuki, et al.
Publicado: (2017)

Optimization and characterization of tRNA-shRNA expression constructs
por: Scherer, Lisa J., et al.
Publicado: (2007)

Design and cloning strategies for constructing shRNA expression vectors
por: McIntyre, Glen J, et al.
Publicado: (2006)

The effects of stem length and core placement on shRNA activity
por: Mcintyre, Glen J, et al.
Publicado: (2011)

Optimization of Duplex Stability and Terminal Asymmetry for shRNA Design
por: Matveeva, Olga V., et al.
Publicado: (2010)

Energy profile and secondary structure impact shRNA efficacy
por: Zhou, Hong, et al.
Publicado: (2009)

Production of Transgenic Calves Expressing an shRNA Targeting Myostatin
por: Tessanne, K, et al.
Publicado: (2012)

Improved siRNA/shRNA Functionality by Mismatched Duplex
por: Wu, Haoquan, et al.
Publicado: (2011)

Suppression of Cancer Progression by MGAT1 shRNA Knockdown
por: Beheshti Zavareh, Reza, et al.
Publicado: (2012)

Using shRNA experiments to validate gene regulatory networks
por: Olsen, Catharina, et al.
Publicado: (2015)

Silencing Human Rb2/p130 with shRNA
por: Leucci, Eleonora, et al.
Publicado: (2007)

Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
por: Su, Yinghan, et al.
Publicado: (2022)

Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev
por: Cardona, Maria E., et al.
Publicado: (2022)

The Pro-Survival Oct4/Stat1/Mcl-1 Axis Is Associated with Poor Prognosis in Lung Adenocarcinoma Patients
por: Su, Yu-Chu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dqd3041rokobn2ohgptp4b9dsa